Northwestern University Feinberg School of Medicine

Department of Anesthesiology

Clinical Trials

As part of an academic medical center, the Department of Anesthesiology at Northwestern University Feinberg School of Medicine aims to improve the human health through scientific research.

About Clinical Trials
Clinical trials test or study drugs, surgical procedures, medical devices, or interventions with human subjects. They look to determine their safety and effectiveness in relation to treating specific diseases. Clinical trials are part of clinical research and are at the heart of all medical advances. Learn more about Clinical Trials at Feinberg.

Department of Anesthesiology Trials
The following searchable list includes all publically recruiting Department of Anesthesiology clinical trials.

Contact Us
Please feel free to contact us with inquiries about any of our ongoing research.

Trials
Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression
This is a observational, multi-center study to assess progression of clinical features, imaging and biologic biomarkers in Parkinson disease (PD) patients compared to healthy controls…
This is a observational, multi-center study to assess progression of clinical features, imaging and biologic biomarkers in Parkinson disease (PD) patients compared to healthy controls (HC) and in PD patient subtypes. The primary objective of this study is to identify clinical, imaging and biologic markers of PD progression for use in clinical trials of disease-modifying therapies.
Genetic Cohort-PD Subjects
• Have at least two of the following: resting tremor, slowness of movement, muscle rigidity
• Parkinson disease diagnosis for 7 years or less
• Male or female 18 years or older
• Confirmation of LRRK2, GBA, or SNCA genetic mutation
• Willing to undergo genetic testing

Genetic Cohort-Unaffected Subjects
• 50 years or older with LRRK2/GBA mutation or first degree relative with LRRK2/GBA mutation
• Willing to undergo genetic testing
OR
• 30 years or older with SNCA mutation or first degree relative with SNCA mutation
• Willing to undergo genetic testing
Simuni, TatyanaSimuni, Tatyana
NCT01141023 STU00031752
More Info

For more information on this study please contact us:

Friedeck, Heidi 312 503 1519
A PHASE 3, RANDOMIZED, DOUBLE BLIND, PLACEBO AND ACTIVE-CONTROLLED, MULTICENTER, PARALLEL-GROUP STUDY OF THE ANALGESIC EFFICACY AND SAFETY OF TANEZUMAB IN ADULT SUBJECTS WITH CHRONIC LOW BACK PAIN
This study will evaluate the effectiveness and long term safety profile of tanezumab 5mg and 10mg treatm…
This study will evaluate the effectiveness and long term safety profile of tanezumab 5mg and 10mg treatment for chronic low back pain compared to tramadol Prolonged Release (PR), a medication commonly utilized for the treatment of chronic low back pain. In addition, this study will evaluate the efficacy of tanezumab compared to placebo for the treatment of chronic low back pain. Tanezumab 5 mg and 10 mg will be administered by subcutaneous injection seven times at 8 week intervals.
Chronic low back pain >3 months, No osteoarthritis, 18 or older
Walega, David RWalega, David R
STU00201561
More Info

For more information on this study please contact us:

Reynolds, Trista 312 472 6475